Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1978-7-26
|
pubmed:abstractText |
The paper presents the results of L-dopa use for the treatment of patients with reactive stuporous states. The assumption concerning curability of these patients is based on the similarity of a number of their clinical and biochemical manifestations with an akynetic-rigid form of parkinsonism where L-dopa is very effective. From 25 patients with reactive psychoses 7 demonstrated recovery, 3 patients--significant improvement, 5 patients--improvement and 10 patients--absence of the effect. The drug is the most effective in the stuporous depth of psychomotor inhibition in persons with a monomorphic structure of stuporous syndromes, rather "frequent" depressive disorders and a decrease of a background level of dopamine excreation with urine. Use of L-dopa in schizophrenic stuporous states (5 patients) was ineffective.
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0044-4588
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
537-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:654727-Adult,
pubmed-meshheading:654727-Antidepressive Agents,
pubmed-meshheading:654727-Catecholamines,
pubmed-meshheading:654727-Cognition Disorders,
pubmed-meshheading:654727-Consciousness Disorders,
pubmed-meshheading:654727-Humans,
pubmed-meshheading:654727-Levodopa,
pubmed-meshheading:654727-Middle Aged,
pubmed-meshheading:654727-Psychotic Disorders,
pubmed-meshheading:654727-Schizophrenia,
pubmed-meshheading:654727-Syndrome
|
pubmed:year |
1978
|
pubmed:articleTitle |
[Treatment of reactive stuporous states with L-DOPA].
|
pubmed:publicationType |
Journal Article,
English Abstract
|